What is it about?
Cancer remains one of the leading causes of death worldwide, highlighting the need for new and more effective treatments. In this study, we developed and synthesized a series of novel sulfonamide derivatives based on a pyrazolotriazine scaffold, structurally related to naturally occurring purines. We investigated these compounds for potential anticancer activity. The findings highlight the promise of this class of molecules as a starting point for developing new anticancer agents. Further studies are needed to understand their mechanisms of action and evaluate their therapeutic potential.
Featured Image
Photo by Towfiqu barbhuiya on Unsplash
Why is it important?
This study's novelty lies in developing seven new sulfonamide derivatives of pyrazolo[1,5-a][1,3,5]triazine as structural analogs of naturally occurring purines. We evaluated their anticancer activity across the NCI-60 panel of human cancer cell lines, revealing promising activity against several cancer types, particularly leukemia, colon, and renal cancers. The most active compound demonstrated submicromolar growth inhibition in selected cancer cell lines. Molecular docking suggested that cyclin-dependent kinases (CDKs), key regulators of cell division, may be involved in the observed anticancer activity. In addition, computational predictions indicated favorable drug-like properties. These findings are particularly relevant to the ongoing search for new anticancer agents with improved activity and selectivity. The identified compounds provide promising starting points for further structural optimization, experimental investigation of their mechanisms of action, and future anticancer drug discovery.
Perspectives
From my perspective, this study highlights the potential of combining rational molecular design, synthetic organic chemistry, and biological evaluation to identify new anticancer compounds. I find the pyrazolo[1,5-a][1,3,5]triazine scaffold particularly interesting because its structural similarity to purines offers opportunities for developing biologically active molecules. The promising anticancer activity observed in several human cancer cell lines strongly motivates further investigation. I believe understanding the structure–activity relationships and identifying these compounds' molecular targets will be essential next steps. I hope our findings will encourage further research into purine bioisosteres and contribute to the discovery of new anticancer agents.
Dr. Ivan V. Semenyuta
V.P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry of the NAS of Ukraine
Read the Original
This page is a summary of: New 4-Benzenesulfonamide Derivatives of Pyrazolo[1,5-a][1,3,5] triazine as Purine Bioisosteres: Development, Synthesis, and Anticancer Perspective, Current Medicinal Chemistry, March 2026, Bentham Science Publishers,
DOI: 10.2174/0109298673385989250711112625.
You can read the full text:
Resources
Contributors
The following have contributed to this page
